annual shareholders equity:
$757.50M+$469.11M(+162.66%)Summary
- As of today (May 29, 2025), NAMS annual stockholders equity is $757.50 million, with the most recent change of +$469.11 million (+162.66%) on December 31, 2024.
- During the last 3 years, NAMS annual shareholders equity has risen by +$701.13 million (+1243.70%).
- NAMS annual shareholders equity is now at all-time high.
Performance
NAMS Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$777.36M+$19.86M(+2.62%)Summary
- As of today (May 29, 2025), NAMS quarterly stockholders equity is $777.36 million, with the most recent change of +$19.86 million (+2.62%) on March 31, 2025.
- Over the past year, NAMS quarterly shareholders equity has increased by +$365.56 million (+88.77%).
- NAMS quarterly shareholders equity is now at all-time high.
Performance
NAMS quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NAMS Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +162.7% | +88.8% |
| 3 y3 years | +1243.7% | +303.5% |
| 5 y5 years | +10000.0% | +1278.9% |
NAMS Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1243.7% | at high | +1278.9% |
| 5 y | 5-year | at high | >+9999.0% | at high | +1278.9% |
| alltime | all time | at high | >+9999.0% | at high | +1278.9% |
NAMS Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $777.36M(+2.6%) |
| Dec 2024 | $757.50M(+162.7%) | $757.50M(+99.9%) |
| Sep 2024 | - | $378.86M(-2.2%) |
| Jun 2024 | - | $387.44M(-5.9%) |
| Mar 2024 | - | $411.80M(+42.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $288.39M(-32.9%) | $288.39M(-37.2%) |
| Jun 2023 | - | $458.89M(+6.7%) |
| Dec 2022 | $430.07M(+662.9%) | $430.07M(+123.2%) |
| Jun 2022 | - | $192.65M(+241.7%) |
| Dec 2021 | $56.37M(-1381.4%) | $56.37M |
| Dec 2020 | -$4.40M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual stockholders equity?
- What is the all time high annual shareholders equity for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual shareholders equity year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly shareholders equity year-on-year change?
What is NewAmsterdam Pharma Company NV annual stockholders equity?
The current annual shareholders equity of NAMS is $757.50M
What is the all time high annual shareholders equity for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual stockholders equity is $757.50M
What is NewAmsterdam Pharma Company NV annual shareholders equity year-on-year change?
Over the past year, NAMS annual stockholders equity has changed by +$469.11M (+162.66%)
What is NewAmsterdam Pharma Company NV quarterly stockholders equity?
The current quarterly shareholders equity of NAMS is $777.36M
What is the all time high quarterly shareholders equity for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly stockholders equity is $777.36M
What is NewAmsterdam Pharma Company NV quarterly shareholders equity year-on-year change?
Over the past year, NAMS quarterly stockholders equity has changed by +$365.56M (+88.77%)